Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.965 SEK | -3.20% | -3.26% | -21.12% |
Apr. 23 | Synact Pharma AB Announces Changes in Nomination Committee Ahead of the 2024 Annual General Meeting | CI |
Mar. 20 | Sweden's SynAct Pharma Names New CEO | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 314M 3.37B |
---|---|---|---|---|---|
Net income 2022 | -99M -1.06B | Net income 2023 | -216M -2.32B | EV / Sales 2022 | - |
Net cash position 2022 | 106M 1.14B | Net cash position 2023 | 61.76M 662M | EV / Sales 2023 | - |
P/E ratio 2022 |
-22.7
x | P/E ratio 2023 |
-1.33
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 69.46% |
1 day | -3.20% | ||
1 week | -3.26% | ||
Current month | +1.83% | ||
1 month | -7.01% | ||
3 months | -21.30% | ||
6 months | +5.85% | ||
Current year | -21.12% |
Managers | Title | Age | Since |
---|---|---|---|
Björn Westberg
DFI | Director of Finance/CFO | 62 | 23-05-31 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | Feb. 14 |
Thomas Boesen
COO | Chief Operating Officer | - | 21-01-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Jonassen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 6.965 | -3.20% | 65 162 |
24-05-21 | 7.195 | +2.86% | 93,548 |
24-05-20 | 6.995 | -2.85% | 45,377 |
24-05-17 | 7.2 | +2.86% | 99,338 |
24-05-16 | 7 | -2.78% | 87,523 |
Delayed Quote Nasdaq Stockholm, May 22, 2024 at 07:56 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-21.12% | 27.76M | |
+44.48% | 55.07B | |
+43.68% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- SYNACT Stock